COMMUNITY HEALTH SYSTEMS INC (CYH) Stock Analysis

Price updated today · SEC data refreshed 2 months ago ⓘ · Not investment advice

COMMUNITY HEALTH SYSTEMS INC

CYH Healthcare Hospitals📄 SEC filings ↗ CUSIP 203668108
Valuation N/A
Long-term trend (200d) 5% below 200-day Risk 66/100 High
▾ What's in the 66/100 risk score? (higher = riskier)
Fundamental health (43%) 92/100 → +39.4
leverage 92/100
Smart money (short interest + insider buying) (31%) 63/100 → +19.8
Macro backdrop (VIX, curve, credit, fear/greed + week-over-week momentum) (26%) 28/100 → +7.2
Total66/100

Contributions (weight × component score) sum to the total. This near-term score now includes fundamental health (leverage, FCF trend). See the Financial Health section for the full balance-sheet read.

💵 Price $3.00 · today 📄 Financials SEC EDGAR · refreshed 2 months ago
📍 START HERE

How to read CYH

We are not publishing an intrinsic value for this one — the section below says exactly why. Everything on this page that comes straight from the filings and the tape is still here; treat the missing valuation as a known gap, not as a verdict on the business.

Where to start — the sections that matter most for this stock
  1. 1 Reported earnings & margins ↓
    What the company actually reported — unaffected by the valuation being held.
  2. 2 Balance sheet & book value ↓
    Assets, liabilities and equity as filed.
  3. 3 Who's selling & betting against it ↓
    Insider and short-interest behaviour needs no valuation model.
Or — what are you trying to decide?
One rule first: never trade out of fear — and that includes the fear of missing out. A stock up 10% a day for three days is excitement, not data. If you can't point to the evidence behind a trade, you're more likely to lose. So whichever of these you are, check the data below before you act.
🚀
"It's surging — should I chase it?"
The momentum / FOMO trade. Before you chase, see whether the people who know it best are quietly selling into the rally.
🏷️
"Is it a cheap bargain?"
The deep-value trade. How far below assets and our value it trades — and whether it's cheap for a reason.
ⓘ Foreign filer — financials appear to be reported in a non-U.S. currency

CYH looks like a foreign company (ADR) whose SEC filings are denominated in its home currency, while the share price is in U.S. dollars. Mixing the two would produce a meaningless dollar fair-value, so we suppress the single intrinsic-value number rather than show a wrong one.

What to use instead: the growth trends, margins and ratios below (which are currency-independent), the peer comparison, and the company's own filings. A currency-converted valuation is on our roadmap.

ⓘ Why does CYH trade at $3.00?

COMMUNITY HEALTH SYSTEMS INC has 135.0 million shares outstanding. At $3.00 per share, the market values all outstanding CYH equity at $405 million. That's market capitalization, not enterprise value — enterprise value also accounts for debt and cash — and it matters here because CYH carries substantial debt. The share price by itself tells you almost nothing — a company can pick any share price by splitting or issuing more shares. What matters is the total value (Market Cap?Market Cap — The total dollar value the market is assigning to the entire company.
Why it matters: This is the number that actually matters when comparing companies. Two companies with the same business but different share counts have the same market cap.
Reference: Mega cap >$200B · Large $10–200B · Mid $2–10B · Small $300M–2B · Micro <$300M
Full explanation →) compared to what the business actually produces. This page values CYH in Per Share?Per Share — A company-level figure divided by total shares — what one share represents.
Why it matters: Per-share metrics are the only way to fairly compare two companies with different share counts.
Full explanation → economics — what each share represents of the underlying business. Play with the share-price calculator on the homepage →

Loading insider & short-seller data…
PEER BASKET — LIMITED COMPARABLES

⚠ We found no genuine same-industry (Hospitals) comparables at all — fewer than the 4 we require for a reliable median. The 8 names in the table below therefore include 8 broader Healthcare names marked fallback, whose business models and margins differ — which is why any median below is computed over that wider set, not over true comparables. So we do not derive a peer-implied share value here. Read the multiples as rough context only.

How does CYH stack up against its closest peers?

Ideally we compare CYH only to same-industry peers, but too few exist in our universe right now, so the basket below mixes in broader-sector names. Treat the multiples as rough context, not a valuation. For a leveraged business, EV/EBIT and FCF yield (both in the table) are usually more reliable than EV/Sales, because revenue multiples ignore differences in margins and debt.

▾ What's "EV / Sales" in plain English?

EV (Enterprise Value) = market cap + total debt − cash. It's "what you'd pay to buy the entire company outright" — you pay the market cap to shareholders and take over their debt, but you keep their cash. EV is fairer than market cap alone because it includes the debt the new owner inherits.

EV / Sales = EV ÷ annual revenue. So "2.5×" means investors pay $2.50 of enterprise value per $1 of yearly sales. Higher = market is paying more per dollar of sales (usually because they expect future growth or fat margins).

p25 / median / p75 are the 25th, 50th (middle), and 75th percentile of the peers' multiples. Half the peers fall between p25 and p75. The median (p50) is the typical peer — that's the benchmark we compare to.

What peers trade at (p25 / median / p75)
EV / Sales?EV / Sales — For every $1 of yearly revenue, this is how many dollars investors pay to own the whole business (including debt).
Why it matters: Works for pre-profit growth companies where P/E and FCF don't apply. The most apples-to-apples cross-company multiple because it ignores accounting choices.
Reference: 1–3x for mature companies · 4–10x for software/SaaS · 10–20x for hypergrowth · >20x is rare and demanding
Full explanation →		 1.4x / 7.1x / 13.7x

Bold middle number = median peer. Half the peers trade above it, half below. Computed over 8 peers (broad — see caveat); implausible multiples excluded.

What CYH would be worth at the median peer's multiple
We're not showing a peer-implied price for CYH: with only 0 genuine same-industry comparables, a median built partly from broader-sector names would be misleading. Lean on the DCF above; use the multiples table only as loose context.

⚠️ Important caveat: peer multiples only work if the peers are genuinely comparable. Always check the peer list below — if the auto-picker grabbed micro-caps or unrelated businesses, the comparison is noise. A medical-device giant priced against tiny biotech startups won't produce a useful signal.

▾ View peer list (8)
Ticker Company Industry Mcap EV/Sales EV/GP EV/EBIT FCF Yield
XFOR X4 Pharmaceuticals, Inc Biotechnology ·fallback $407M 13.7x — — 1.0%
VNDA Vanda Pharmaceuticals Inc. Pharmaceuticals ·fallback $388M 1.8x — — 3.7%
VSTM Verastem, Inc. Pharmaceuticals ·fallback $380M 12.3x — — 5.6%
VMD VIEMED HEALTHCARE, INC. Misc Health & Allied Servi ·fallback $377M 1.4x 2.5x 16.9x 32.2%
UPB Upstream Bio, Inc. Pharmaceuticals ·fallback $455M 159.4x — — 0.1%
ZBIO Zenas BioPharma, Inc. Pharmaceuticals ·fallback $456M 53.4x — — 0.1%
ZJYL Jin Medical International Ltd. Medical Devices ·fallback $351M 17.0x 58.0x 576.6x 0.3%
USNA USANA HEALTH SCIENCES INC Pharmaceuticals ·fallback $338M 0.4x 0.5x 9.0x 30.6%
FINANCIAL HEALTH SCREENS

Bankruptcy + quality screens

Cheap stocks can be cheap for a reason. These screens warn when a low valuation comes paired with structural fragility.

Altman Z-Score?Altman Z-Score — A bankruptcy-risk score combining 5 financial ratios into one number. Predictive of bankruptcy within 2 years.
Why it matters: Cheap-looking stocks (low P/E or P/B) often have low Z-scores because the market knows the company is dying. Z-score warns you before you fall into a value trap.
Reference: > 3.0 = safe zone · 1.81–3.0 = grey zone · < 1.81 = distress zone
Full explanation →
1.43
Distress zone

Distress zone under the classic Altman thresholds — scores here have historically preceded a high rate of financial distress within ~2 years. This is a warning signal, not a direct bankruptcy probability, and its reliability varies by industry. Be very skeptical of any "cheap" valuation on this name.

The classic Z-score was calibrated on manufacturers. It is less reliable for asset-light or non-manufacturing businesses (broadcasters, media, software, services) and not applicable to banks, REITs, or insurers — for those the coefficients and the asset-turnover term distort the result. Read it as one screening input, not a verdict.

Piotroski checks
7 passed · 1 failed · 1 n/a
Partial result, not a standard F-score: 7 of 8 measurable checks passed. 1 of the 9 standard checks couldn't be measured, so this is scored out of 8, not 9 — it isn't comparable to a published F-score.
▾ The checks — what passed, what didn't (and what we couldn't measure)
  • ✓ Positive net income
    Net income $509.0M in the latest year.
  • ✓ Positive operating cash flow
    Operating cash flow $543.0M (was $480.0M the prior year).
  • ✓ Cash flow backs up reported profit
    Operating cash flow $543.0M vs net income $509.0M.
  • ✓ Return on assets improving
    Return on assets 3.9% vs -3.7% a year ago.
  • ✓ Debt load (vs assets)
    Long-term debt is 78.7% of assets vs 81.3% a year ago ($10,396.0M now).
  • ✓ Short-term liquidity (current ratio)
    Current ratio 1.46x vs 1.41x a year ago.
  • ✗ Share count (dilution)
    Share count rose 2.2% (132.1M → 135.0M year-over-year).
    Why this matters: Issuing lots of new shares splits the pie into more pieces, shrinking your slice. Stable or falling share count protects existing owners.
  • · Pricing power (gross margin) (n/a — data not reported; not scored)
  • ✓ Sales per asset (asset turnover)
    Asset turnover 0.95x vs 0.90x a year ago.

Missing data is never counted as a pass or a fail — it's shown as n/a and excluded from the denominator. Each check compares the company against its own prior year.

INTERACTIVE — TWEAK YOUR ASSUMPTIONS

What if you assume different inputs?

Here's where we land — and what happens if you change the assumptions. Drag the sliders to set your own Discount Rate?Discount Rate — The annual return you demand for taking single-stock risk instead of buying a safe Treasury or index fund.
Why it matters: Higher discount rate = stricter valuation (a stock has to produce more cash to be worth holding). Lower = more generous.
Reference: 8–12% is standard · 9–10% matches S&P 500 historical return · Below 7% is illogical for single-stock risk
Full explanation → (the annual return you demand for single-stock risk) and terminal growth; the value updates live so you can see whether the stock looks cheaper or richer. The discount rate starts at 10.0%, the figure our model used for CYH. Open Advanced to also change beta, growth and the rate path.

Note: no headline intrinsic value is published for this stock (the valuation is held for a data-quality reason — see the notes above). The calculator below is a what-if tool: the values it produces are your assumptions played out, not our estimate.

4.5% (risk-free)9-10% normal18% (deep-risk)
0%2-3% (GDP)5% (rarely sustainable)

A full intrinsic value isn't shown for CYH because the valuation is currently held for a data-quality reason (see the guardrail notes above). The reverse-DCF reading still works — it needs only the price and cash flow — but we won't publish a forward value until the underlying data passes our checks.

For comparison — the revenue growth today's price already assumes
—
—

—

⚙ Advanced — tinker with every input (beta, growth, rate path, margin → full intrinsic value)
Where the discount rate comes from — discount rate = risk-free + beta × equity-risk-premium
What you'd earn risk-free from government bonds — the floor under every other rate. Slide it down to model the market expecting rate cuts (value rises); up for higher-for-longer.
The extra yearly return investors demand for owning stocks instead of safe bonds — the price of risk. History runs ~4.5–6.5%; we default to 5.5% (slightly conservative). It's an estimate, not a law — lower it if you think equities are less risky than that.
Inflation quietly eats returns: a 9% gain at 3% inflation is only ~6% in real purchasing power. The intrinsic value above is already in today's dollars (a nominal DCF cancels inflation out of both growth and the discount rate), so this doesn't change the value — it shows what's left of your return after the tax.
Higher beta → higher discount rate (sets the rate above). 1.0 = moves with the market.
What you think CYH can grow revenue for ~5 years, then fades to terminal.
For a pre-profit company: the % of revenue that eventually becomes free cash flow once mature. (Our published value uses the sector norm.)
All inputs start at the values our model used.

    Copy shareable link to this scenario →

    Price$3.00
    Model IVNot applicable — DCF couldn't price this stock. See Reverse DCF and Football Field below.

    Community Health Systems Inc. (CYH) trades at a deep discount of 83.8% to the model's intrinsic value?Intrinsic Value — Our DCF model's estimate of what each share is mathematically worth based on projected cash flows.
    Why it matters: Compare to current price. Below IV = potentially undervalued. Above IV = priced for growth that must actually happen.
    Reference: Model-derived; quality depends on data and assumptions.
    Full explanation →    . This significant discount likely reflects the market's concern over the company's roughly flat revenue growth and its low franchise/durability score of 1/5, despite recent positive net income and operating cash flow. The number one quantifiable risk is the market's implied decline rate of 20.0% compared to the model's 3.2%.

    ⚠️ Terminal growth (3%) capped to 2.5% (80% of near-term growth 3.2%).

    As of 2 months ago

    ANATOMY

    Anatomy of a share

    What you're buying per share. Bars are at the same scale so you can see the relative size of revenue, costs, cash flow, and debt — not just read them in a table.

    CYH COMMUNITY HEALTH SYSTEMS INC stock anatomy showing per-share revenue, operating expenses, free cash flow, and debt
    4.1%
    profit
    Where each $1 of revenue goes
    Net profit — 4.1¢ of every dollar ($3.77/sh — latest fiscal-year net income per share)
    Costs & taxes — 95.9¢ (on $92.47 revenue/sh)
    Net margin = net income ÷ revenue (most recent fiscal year).
    Plain English: $3/share buys $92.47 of revenue per share per year, generates $3.77 of net income per current share, and $1.46 of free cash flow per share. Each share carries $77.00 of debt.
    What's free cash flow / what do these mean?

    Revenue per share — how much the business earns from customers, divided by the number of shares outstanding. Top of the income statement.

    Earnings per share — profit left after operating costs, interest, and taxes, per share. Two versions appear on this page and are not interchangeable: GAAP diluted EPS uses the company's weighted-average diluted share count during the reporting period (this is the "earnings" in "price-to-earnings"); net income per current share divides annual net income by today's share count. They differ whenever the share count has changed.

    Owner-earnings free cash flow per share — the cash the business produces for shareholders. Savng's owner-earnings FCF subtracts capital expenditures and stock-based compensation from operating cash flow (SBC is a real dilution cost even though it's non-cash). This is deliberately more conservative than "standard" FCF, which subtracts only capital expenditures — so our figure is lower than the headline FCF you'll see elsewhere. FCF funds dividends, buybacks, debt repayment, and acquisitions; a company can report positive earnings yet negative FCF.

    Debt per share — total interest-bearing borrowings divided by shares. High debt-per-share next to thin FCF-per-share is a fragility signal.

    THE KEY DEBATE

    What you actually need to decide

    Every stock price is a disagreement. Here's the single thing that must go right for the bulls, the single thing that breaks the thesis, and the concrete signposts to watch so you can update your view as real results arrive.

    🐂 The Bull Case
    For the stock to work, the company must demonstrate sustained revenue re-acceleration beyond the current 0.2%/yr growth, potentially driven by improved patient volumes or service offerings. Operating cash flow must remain consistently positive and grow.
    🐻 The Bear Case
    The biggest fundamental risk is the continuation of roughly flat revenue growth combined with a low franchise/durability score of 1/5, which implies a lack of competitive advantage and potential for further market share erosion.
    📌 Signposts to watch — update your view as these print
    • Next quarter's revenue growth rate
    • Trend in operating cash flow
    • Updates on debt reduction efforts
    MOMENTUM — WHAT'S GETTING BETTER & WORSE

    The trend, in plain numbers (2024 → 2025)

    Straight from the financial statements — no model, no opinion. For a small or unprofitable company, the direction of these numbers usually tells you more than any single valuation.

    ✅ Improving
    • Free cash flow rose to $197.0M.
    • Swung to a profit of $509.0M (from a loss the prior year).
    ⚠ Worsening
    • Revenue fell -1% to $12.49B.
    WHO

    Management & Leadership

    Tim H. Hingtgen serves as the Chief Executive Officer of Community Health Systems, a role he has held since 2020, having previously served as President and Chief Operating Officer. Wayne T. Smith is the Executive Chairman of the Board, having previously served as CEO.

    Tim H. Hingtgen
    Chief Executive Officer
    Wayne T. Smith
    Executive Chairman
    WHAT

    What They Make

    Community Health Systems operates general acute care hospitals and related healthcare services. They provide a range of inpatient and outpatient services to patients in non-urban and selected urban markets.

    End Markets

    Acute Care HospitalsOutpatient ServicesHealthcare Services

    Revenue Drivers

    Inpatient admissions
    Outpatient visits
    Surgical procedures
    Market Cap: 405.0MBeta: 1.18
    WHY

    Why Is It Priced Like This?

    Why Customers Pay

    Access to essential healthcare services
    Comprehensive medical treatment options
    Local community healthcare provider
    No discounted-cash-flow value for this filer This company reports its financials in its home currency while the shares trade here in dollars. Mixing the two produces a per-share value that looks real but isn't, so we hold the valuation rather than publish a number we can't stand behind. The reported figures below are the company's own.

    What we use instead: earnings (P/E, EV/EBIT), book value (P/B) — computed from the figures this company does report, shown in the sections below. Those numbers are unaffected by the missing cash-flow data.

    The market prices CYH at an 83.8% discount, likely due to its roughly flat revenue growth of 0.2%/yr over four years and a low franchise/durability score of 1/5. While net income and operating cash flow have been positive recently, the market appears to be discounting the stock heavily, implying a 20.0% decline rate, reflecting concerns about its long-term competitive position and growth prospects.

    HOW

    Business Model & Valuation

    How They Make Money

    Hospital service fees from patient care
    Reimbursements from government programs (Medicare/Medicaid)
    Payments from commercial insurance providers

    The company has been reducing its long-term debt, which fell from $12109M to $10396M, indicating a focus on debt reduction rather than dividends or buybacks.

    Free Cash Flow DCF

    Standard FCF DCF: positive free cash flow in a sector suited for cash-flow-based valuation. FCF negative in 3/5 years.

    Show advanced inputs
    RevenueGrowth0.2%
    HistoricalFcfGrowth91.3%
    SectorDefault10.0%
    BestEstimate3.2%
    Methodblend(70% revenue_cagr, 30% sector)
    GrowthBasistotal

    What this model does NOT do: this is a consolidated owner-earnings FCF model. Standalone segment assumptions: none. It does not project its revenue segments independently; their combined effect is embedded in the historical revenue and cash-flow trend the model extrapolates. The calculator above can only approximate a segment's impact through the single consolidated growth rate — it cannot model any one line separately. For a true segment-level view, build a separate model from the company's segment disclosures.

    WHEN

    Maturity & Competitive Position

    Mature compounder

    Moat Signals

    Established hospital network
    Local market presence
    Integrated healthcare services

    Revenue has been roughly flat, growing at 0.2%/yr over the past four years.

    WHERE

    Geography & Markets

    Community Health Systems primarily operates hospitals and healthcare facilities across various states in the United States. Specific geographic segment percentages are not available from current data sources.

    Geographic Risks

    Regulatory changes in healthcare policy
    Reliance on government reimbursement programs
    SIGNALS

    Market Signals

    These are timing signals, not value signals — they describe the stock's recent price behavior, not what the business is worth. Use them for the "the thesis looks good, but is now the moment?" question. Each tile below explains what it's saying.

    Model bullish, tape bearish - divergence suggests timing risk.
    RSI?RSI — Relative Strength Index — a 0-100 momentum gauge. Above 70 = overbought; below 30 = oversold.
    Why it matters: Short-term contrarian indicator. Extreme readings often precede mean reversion, though not always.
    Reference: 30–70 normal · >70 overbought · <30 oversold
    Full explanation →     (14)    41.2NeutralMomentum is balanced — neither overbought nor oversold.
    MACD?MACD — Moving Average Convergence Divergence — compares a fast and a slow price trend to gauge momentum direction.
    Why it matters: When the fast line crosses above the slow line, short-term momentum is turning up; below, turning down. A timing cue, not a value signal.
    Reference: Line above signal = bullish momentum · below = bearish
    Full explanation →    BearishLine below signalThe fast trend is below the slow trend — short-term momentum is currently downward.
    50-Day Average$2.91Price above (+3.1%)Price above its 50-day average = near-term uptrend.
    200-Day Average$3.15Price belowThe 200-day line is the long-term trend divider — above it is generally considered a bull market for the stock.
    50 vs 200 CrossDeath50-day below 200-dayA "death cross" — the medium trend is below the long trend (often read as bearish).

    Technicals describe price, not the business. A great company can have a "bearish" tape (a buying chance) and a weak one a "bullish" tape (a trap). Pair these with the valuation and health sections above.

    QUALITY

    Data Quality & Risk Flags (2 notes — click to expand/collapse)
    Guardrail Notes (2)
    • Terminal growth (3%) capped to 2.5% (80% of near-term growth 3.2%).
    • Illiquidity discount 7% applied (small/micro-cap — harder to exit, demand a margin).
    FINANCIALS

    Financial Statements (5-year tables — click to expand)

    From COMMUNITY HEALTH SYSTEMS INC's SEC filings (EDGAR).

    Income (5yr)

    YearRevenueNet IncomeEPS
    202512.5B509.0M$3.77
    202412.6B-516.0M$-3.90
    202312.5B-133.0M$-1.02
    202212.2B46.0M$0.35
    202112.4B230.0M$1.76

    Cash Flow (5yr)

    YearOperating CFCapEx− SBC & adj.Free Cash Flow
    2025 543.0M 335.0M 11.0M 197.0M
    2024 480.0M 360.0M 17.0M 103.0M
    2023 210.0M 467.0M 22.0M -279.0M
    2022 300.0M 415.0M 20.0M -135.0M
    2021 -131.0M 469.0M 25.0M -625.0M

    How we define FCF: operating cash flow − capital expenditure − stock-based compensation (owner-earnings basis — SBC is a real cost to shareholders even though it's non-cash). Latest year: 543.0M − 335.0M − 11.0M (SBC & adj.) = 197.0M. This is the same owner-earnings FCF definition the valuation model uses.

    Balance Sheet

    Total Assets13.2B
    Total Liabilities14.0B
    Equity-1.4B
    Total Debt10.4B
    PG
    Methodology by Pouyan Golshani, MD — founder of Gighz. Savng was built by a physician for busy professionals: every number on this page comes from SEC filings (EDGAR) and FINRA data through transparent, rules-based models — no analyst opinions, no hidden inputs. How we calculate every number →
    ⚠️ Not investment advice. Automated model outputs, last refreshed May 30, 2026 (the analysis-refresh date, not the latest filing period). All models have blind spots. Full disclaimer →
    ← Browse Stocks See sector peers →
    🔔 Follow $CYH — free insider alerts
    One email when an insider buys $CYH on the open market with their own cash — or notably sells outside a scheduled plan. Routine and automated trades filtered out. Follow up to 3 stocks free; Portfolio Watch covers your whole list plus valuation & risk alerts. Double opt-in, unsubscribe anytime.